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 INTRODUCTION 
 Parasitic infections are often considered as homogeneous 
entities, but there is growing evidence that infections of most 
parasite species commonly consist of multiple genetically dis-
tinct strains. 1– 5 This diversity can have profound effects on 
infection and disease progression, transmission dynamics, and 
clinical patient management. For example, different strains of 
the protozoan blood parasite  Trypanosoma brucei can inhibit 
each other, resulting in lower parasitemia and enhanced 
host survival in individuals co-infected with two strains. 6 In 
 Plasmodium falciparum , increased multiplicity of infection 
can increase or decrease the risk of clinical malaria, depending 
on host age and disease prevalence. 7 Multiple strain infections 
can thus benefit the host in certain circumstances. Moreover, 
multiple strain infections are important to recognize in clini-
cal settings in cases where strains respond differently to treat-
ment or other interventions. For instance, treatment regimes 
may fail if they are directed only toward the dominant strain, 
with concurrent strains not being recognised and targeted. 8, 9 
 Trypanosoma brucei , transmitted by the bite of the tse-
tse fly ( Glossina spp.) vector, 10, 11 causes invariably lethal 
human African trypanosomiasis (sleeping sickness) and ani-
mal Nagana in remote rural parts of sub-Saharan Africa. 
Human disease is caused by two sub-species,  Trypanosoma 
brucei rhodesiense (Eastern and Southern Africa, acute dis-
ease course) and  Trypanosoma brucei gambiense (Western 
and Central Africa, chronic disease progression), whereas 
 T. b. brucei is non-human infective. 12, 13 Different strains of 
 T. brucei exhibit considerable variability. A study in Uganda 
showed for instance genetic differences in  T. b. rhodesiense 
infections between two different rural villages (e.g., Tororo 
and Soroti). These intra-parasite variations are reflected in 
the patient immune response and consequently in disease 
progression. 14 In view of multiple strain infections being 
common in  T. brucei , 1 it is important to further our understand-
ing of hosts co-infected with different strains of  T. brucei . 
 Nuclear magnetic resonance (NMR) spectroscopy-based 
metabolic profiling has emerged as a powerful approach to 
investigate mechanisms of host-parasite interaction and shows 
promise for early disease diagnosis. 15 The multivariate struc-
ture of NMR spectral data requires appropriate statistical anal-
ysis to elucidate and interpret complex datasets with typically 
more variables than samples. 16 Widely used methods include 
unsupervised principal component analysis (PCA), which pro-
vides an overview of the intrinsic similarities and differences 
in a dataset revealing groupings, outliers and time trajecto-
ries, and supervised orthogonal signal corrected-projection 
to latent structure-discriminant analysis (O-PLS-DA). 17 The 
latter method is particularly suitable for identifying system-
atic changes relating to distinct classes (e.g., infected versus 
non-infected control groups). 18 A series of host-parasite inter-
actions have been investigated at the molecular level, both 
for helminths and protozoan. 19 However, although multipar-
asitism is the norm rather than the exception in developing 
country settings, 20, 21 little attention has been paid to interac-
tions between multiple strains of a single parasite or differ-
ent species of parasites co-infecting a single host. Recently,  1 H 
NMR spectroscopy-based metabolic profiling has been used 
to characterize the global responses in the hamster to two hel-
minth species. 22 To our knowledge, differences among multiple 
strains of a single parasite species have yet to be investigated 
in a systematic manner. Recently, the metabolic profile of sin-
gle strain  T. b. brucei infections in mice has been studied and a 
broad range of metabolic changes involved in energy metabo-
lism, symbiotic microbiota-related metabolism, and inflamma-
tory response were found. 23 Here, we take our previous study 
a step further. We used two different  T. b. brucei strains and 
determined whether they cause different metabolic responses 
in the same host and whether the metabolic profiles of multi-
ple strain infections differ from single infections to discern the 
interactions between the different strains. 
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 MATERIALS AND METHODS 
 Study approval, parasite strains, and mice.  The study was 
approved by the veterinary department of Basel-Stadt, Switzer-
land (permit no. 2073). Two  T. b. brucei strains, STIB246BA-R1 
(subsequently called “ red ”) and STIB777AE-G1 (subsequently 
called “ green ”), transfected with a red and green fluorescent 
protein gene, respectively, to enable visual distinction for 
individual population density tracking, 24 were used to infect 
33-day-old outbred female NMRI mice ( Mus musculus ; 
purchased from RCC Ltd., Itingen, Switzerland). The two 
strains derive from independent isolations (from a kongoni 
[ Alcelaphus buselaphus ] in Tanzania and a tsetse fly [ Glossina 
fuscipes ] in Uganda, respectively) and are distinct in nuclear 
 COI sequence and microsatellite markers. 25 
 This study is a further analysis of the “equal virulence exper-
iment” presented elsewhere 6 with  green corresponding to 
strain  green VIR in that study. Strain  green VIR was preferred over 
 green AVIR 
6 because it exhibits identical growth characteristics 
to  red , so that different metabolic responses can be attributed 
to the strain (genotype) rather than to its growth characteris-
tics (phenotype). Mice were kept in cages with a maximum of 
five animals per cage and provided food and water  ad libitum . 
All mice in one cage belonged to different experimental treat-
ments to avoid systematic cage effects. 
 Experimental design and infections.  Five mice each were 
infected intraperitoneally with 300 μL of saline solution 
containing 1) 10 7 parasites of  red (“red treatment,” R 7 ); 2) 10 
7 
parasites of  green (“green treatment,” G 7 ); 3) 10 
7 parasites of 
 red and 10 5 parasites of  green (“mixed treatment,” R 7 G 5 ); 4) 
10 7 parasites each of  red and  green (“mixed treatment,” R 7 G 7 ); 
or 5) no parasites (“uninfected control”). 
 Sample collection, measurements, and statistical analysis. 
 Measurements were taken daily until day 4 postinfection. 
Parasite density (parasitemia, expressed as parasites per mL 
host blood), mouse weight (g), erythrocyte (red blood cell), 
and thrombocyte concentrations (per mL host blood) were 
measured. Parasite and blood cell counts were determined by a 
Becton Dickinson FACScan flow cytometer (Becton, Dickinson 
and Company, Franklin Lanes, NJ) using the first drop of tail 
blood as described elsewhere. 24 Apart from the metabolic 
analysis (see below), statistical analyses were performed 
using R version 2.8.1 26 with details provided elsewhere. 6 
 Urine and fecal samples for metabolic analyses were col-
lected between 06:00 and 08:00 hours, followed by mouse 
weight and blood measurements, to minimize metabolic varia-
tion caused by diurnal fluctuation, 1 day before the infection 
and at days 1, 3, and 4 postinfection. Although the “equal vir-
ulence experiment” was continued until host death, 6 sample 
collection for the current metabolic profiling study was halted 
at 4 days postinfection, because several animals were already 
moribund and thus loss of the more subtle strain-related vari-
ation would be expected. We aimed at collecting a minimum 
of 30-μL urine per mouse at each sampling time point, which 
was difficult for some individuals because of general ill health 
and potential dehydration. We did not separate mice into 
individual cages to generate more biofluid samples to avoid 
stress-related changes. Samples were kept at −40°C before 
NMR-based metabolic profiling. 
 1 H NMR spectroscopy and multivariate data analysis.  For 
each urine sample, 30 μL of urine were mixed with 25 μL 
of sodium phosphate buffer (pH 7.4) containing 0.01% sodium 
3-(trimethylsilyl) propionate-2,2,3,3-d 4 (TSP) for spec trum 
calibration, 10% H 2 O and 90% D 2 O for field lock of spec-
trometer, and 3 mM Na-azide for eliminating eventual bacterial 
contamination, was transferred into a capillary NMR tube with 
an outer diameter of 1.7 mm for NMR analysis. For each fecal 
sample, two fecal pellets (~0.06 g) were transferred into a 1.5 mL 
Eppendorf tube (Natick, MA) containing 750 μL of phosphate 
buffer as in urine sample preparation, homogenized and 
sonicated for 30 min. Approximately 600 μL of supernatant 
was transferred into an NMR tube with an outer diameter of 
5 mm for NMR analysis following centrifugation at 10,000  g 
for 10 min. All samples were analyzed on a Bruker 600 MHz 
spectrometer (Bruker; Rheinstetten, Germany), operating 
at 600.13 MHz at a temperature of 27°C. A standard pulse 
sequence (recycle delay [RD]-90°- t 1 -90°- t m -90°-acquisition) 
was used to acquire one-dimensional (1-D) spectra. The 
saturation of the water signal was achieved during the mixing 
time ( t m ) of 100 ms and RD of 2 s. The 90° pulse was adjusted 
to ~10 μs and  t 1 was set to 3 μs. A total of 256 scans were 
accumulated into 32,768 data points with a spectral width of 
20 ppm. For the purpose of metabolite identification, two-
dimensional (2-D) spectra were also acquired from selected 
samples based on our previously published parameters. 15 
 Phased, baseline corrected, and calibrated spectra were 
imported into MATLAB software (MathWorks, version 
7.8.0.347 ) for multivariate data analyses. The spectral region 
containing the water resonance (δ 4.6–5.0) was removed to 
minimize the distortion effect of the water peak on the base-
line and the regions between δ 5.3 and 6.3 were also omitted 
because partial cross saturation of the urea signal at this region 
would bias the analysis. 16 Normalization to the total area of 
the remaining spectrum was applied to each spectrum before 
conducting multivariate data analyses. 
 The PCA with unit variance scaling 17 and O-PLS-DA 18 were 
used for multivariate data analyses. The PCA generates scores 
plots, which allow clusters and structures within a dataset to 
be visualized, and loadings plots that indicate which vari-
ables contribute the highest weighting to the distribution of 
the samples in the scores plot. In the O-PLS-DA algorithm, 
the  X matrix comprised observations (NMR spectra) and the 
 Y matrix contained class information (e.g., infection status). 
There was evidence of strain-related metabolic differences 
in the PCA scores plots, and hence O-PLS-DA models were 
constructed on the basis of unit variance scaled NMR spec-
tral data with one PLS component to discriminate two infec-
tion statuses (e.g., uninfected control versus infected; single 
infection versus multiple strain infection), and one orthogo-
nal component that removes systematic variation unrelated to 
the class discrimination. Because the number of animals per 
group was relatively small ( N = 5; caused by adherence to the 
3R rule: reduce, refine, and replace), four quantitative metrics 
were used to assess the quality of each model. R 2 X describes 
the goodness of fit of a model and represents the proportion 
of variation in  X explained by the model. The predictivity of a 
model, Q 2 Y , measures how well the  Y matrix can be predicted. 
Sensitivity is defined as  tp /( tp +  fn ) and specificity as  tn /( fp + 
 tn ), where  tp stands for true positive (an observation or a sam-
ple from a group that is correctly classified as that group) and 
 tn stands for true negative (a sample not from a specific group 
that is correctly classified as a non-member of this specific 
group). The  fp and  fn stand for false positive and false nega-
tive, respectively (incorrect membership classifications). 27 
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 For the four most significantly altered urinary metabolites 
following experimental infection, NMR signal integration was 
performed to establish whether these metabolites showed a 
quantitative relationship with parasitemia levels. Integrals 
were calculated from minimally overlapped peak areas for 
each metabolite (δ 2.373–2.388 for pyruvate, δ 4.015–4.029 for 
4-hydroxyphenylpyrvate, δ 7.401–7.448 for phenylpyruvate, 
and δ 7.813–7.868 for hippurate), and the resulting values taken 
as the relative concentration of each metabolite in the spectra. 
 RESULTS 
 Host fitness, parasitemia, and blood values.  Host survival 
time after infection and erythrocyte and thrombocyte counts 
did not differ between the four infected groups at any day 
postinfection but were significantly different from uninfected 
control mice on day 4 (all  P < 0.05). All measures significantly 
changed over time in infected, but not in uninfected control 
mice ( Table 1 ). The two strains were both suppressed in the 
two mixed treatments (R 7 G 5 and R 7 G 7 ) such that the combined 
total parasitemia per host reached the same density as each 
strain alone in single infections. 
 1-D  1 H NMR spectroscopic analysis of fecal water extract. 
 There were no significant changes in spectral data obtained 
from fecal water extracts between uninfected control and 
 T. b. brucei -infected mice of any infection treatment, corrob-
orating previous findings in mice experimentally infected with 
the intestinal fluke Echinostoma caproni 26  and  Plasmodium 
berghei , 28  and underscoring that fecal water extracts are less 
suitable than other biological samples, e.g., uring or plasma. 29 
 1-D  1 H NMR spectroscopic analysis of urine.  All infected 
mice showed similar  1 H NMR spectral composition in urine 
at day 4 postinfection. However, the urinary metabolic 
profiles obtained from infected mice were markedly different 
from those of uninfected control mice, particularly in the 
aromatic regions, where levels of 4-hydroxyphenylpyru vate, 
phenylpyruvate, and 4-hydroxyphenylacetate were elevated, 
and hippurate was depleted among infected mice ( Figure 1 ). 
Levels of lactate and D-3-hydroxybutyrate were also increased. 
A doublet at δ 1.08, which correlated with peaks at δ 2.50, 
δ 3.54, and δ 3.70 observed in a  1 H- 1 H 2-D NMR total 
correlation spectroscopy spectrum, was provisionally assigned 
as 3-carboxy-2-methyl-3-oxopropanamine in accordance with 
previous investigations in the  T. b. brucei -mouse model. 23 
 Table 1 
 Host survival postinfection, total parasitemia, and decrease of host body condition (mean ± SD) over time in the different  Trypansoma brucei 
brucei infection treatments in mice 
Infection treatment
Control R 7 R 7 G 5 R 7 G 7 G 7 
Survival > 525 99.1 ± 10.4 103.1 ± 17.6 100.0 ± 16.9 100.0 ± 12.0
log 10 (parasitemia) 0 ± 0 9.50 ± 0.08 9.37 ± 0.09 9.43 ± 0.08 9.42 ± 0.08
Anemia −0.2 ± 17.5 27.7 ± 10.0 ** 26.3 ± 12.8 * 33.3 ± 7.2 ** 31.9 ± 16.4 * 
Thrombocytopenia −7.6 ± 9.9 84.8 ± 1.3 *** 80.1 ± 5.0 ** 84.5 ± 5.0 ** 86.4 ± 3.0 *** 
 Survival = survival after infection in hours (experiment stopped after 525 hours); parasitemia = total parasite density per mL of mouse blood on day 4 postinfection ( red and  green combined in 
mixed infections); anemia = % decrease in erythrocyte counts from the start (average of days 0 and 1 postinfection) to the final measurement (day 4); thrombocytopenia = % decrease in throm-
bocyte counts from the start (average of days 0 and 1 postinfection) to the final measurement (day 4). Asterisks indicate significance of paired  t tests on differences between parameter start values 
vs. values on day 4,  *,  P < 0.05;  **,  P < 0.01;  ***,  P < 0.001. 
 Figure 1.  Typical 600 MHz high-resolution  1 H nuclear magnetic resonance (NMR) urinary spectra from ( A ) an uninfected control mouse 
and ( B ) a mouse with a 4-day-old co-infection of  Trypanosoma brucei brucei strains STIB246BA-R1 ( red ) and STIB777AE-G1 ( green ). Key: 
1, 2-oxoisocaproate; 2, 3-methyl-2-oxovalerate; 3, 3-carboxyl-2-methyl-3-oxopropanamine*; 4, 2-oxoisovalerate; 5, D-3-hydroxybutyrate; 6, 
acetate; 7, succinate; 8, 3-aminopropionic acid; 9, 2-oxoglutarate; 10, trimethylamine; 11, citrate; 12, dimethylamine; 13, creatine; 14, trimethylam-
ine  N -oxide; 15, malonate; 16, taurine; 17, glycine; 18, phenylacetylglycine; 19, alanine; 20, hippurate; 21, lactate; 22, 4-hydroxyphenylacetic acid; 23, 
phenylpyruvate; 24, 4-hydroxyphenylpyruvate; 25, creatinine; 26, 1-methylnicotinamide; 27, guanidoacetate*; 28, pyruvate; 29, methanol; 30, formate. 
* Tentative assignment based on chemical shift comparison with literature values. 
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 PCA of  1 H NMR urinary spectra.  The PCA analysis of 
the urinary spectra obtained from all mice at all time points 
was performed and nine outliers were observed, six of which 
had poor quality  1 H NMR spectra caused by an insufficient 
quantity of urine (< 30 μL) for NMR analysis. The remaining 
three samples obtained at day 4 postinfection mapped outside 
the Hotelling 95% confidence ellipse caused by much higher 
concentrations of lactate and pyruvate (4- and 1.75-folds 
greater than the mean of other infected animals at day 4, 
respectively). These samples exerted a strong leverage on 
the model such that strain-related variation was obscured. 
Therefore, the PCA model was recalculated after removal of 
these samples to uncover the systematic metabolic variation 
related to parasitic strain effect. In the resulting PCA scores 
plot, animals clustered according to the progression of 
infection with a clear time-related trajectory along the first 
principal component ( Figure 2A ). Uninfected control mice, 
the preinfection time point (D −1 ) and early stage infection time 
point (day 1 postinfection, D 1 ) grouped together as shown in 
 Figure 2A and were separated from later stage infection time 
points (D 3 and D 4 ). On day 3, mice singly infected with  green 
were closer to the cluster of control and early stage of infection 
 Figure 2.  Principal component analysis (PCA) trajectory scores plots. ( A ) Plot derived from urinary nuclear magnetic resonance (NMR) spec-
tra of all mice 1 day preinfection (black) and on days 1 (no fill), 3 (grey), and 4 (black radial) postinfection (G 7 ; “square,” R 7 ; “hexagon,” R 7 G 5 ; 
“triangle,” R 7 G 7 ; “star”). The group of uninfected mice (black) contains the measurements of all treatments before infection and measurements 
of uninfected control mice on days 1, 3, and 4 in this graph. The first two principal components (PC1 and PC2) explain 26.3% and 10.6% of total 
variance in the data, respectively. Sub-level PCA time trajectory plots derived from treatments ( B ) R 7 , ( C ) G 7 , ( D ) R 7 G 5 , and ( E ) R 7 G 7 showing 
differentiation of preinfection (D −1 ) and postinfection at each time point (D 1 , D 3 , and D 4 ). See  Table 2 for treatment details. This figure appears in 
color at  www.ajtmh.org . 
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than mice with other infection treatments. According to the 
loadings plot (not shown), mice in the late stage of infection 
were clearly distinguished from control mice and mice at early 
stages of infection by higher concentrations of phenylpyruvate 
and 4-hydroxyphenylpyruvate. 
 Sub-level PCA time trajectory plots of each infection treat-
ment are displayed in  Figure 2B – E , which were calculated on 
the basis of the average of scores from all mice at each time 
point with the same infection treatment. These sub-level PCA 
time trajectory plots further illustrate clearly time and disease 
progression-dependent patterns with significant metabolic 
deviations, such as pre- and early infection time point versus 
day 4 postinfection in all four cases, while the sub-level PCA 
trajectory plot derived from the control mice (not shown) 
exhibits substantial standard deviations for each time point, 
and hence no significant temporal movement. 
 O-PLS-DA on  1 H NMR urinary spectra.  The O-PLS-DA 
models were constructed to discriminate mice in the differ-
ent infection treatments from uninfected controls at various 
time points. The predictivity values (Q 2 Y ) of each O-PLS-DA 
model and the correlation coefficients of differentiating 
metabolites are summarized in  Table 2 . Given the sample 
size of five animals in each treatment, a correlation coeffi-
cient above 0.75 was considered significant ( P < 0.05). 30 On 
day 1 postinfection, no difference was observed between 
control and any type of infection. The predictivity measure 
(Q 2 Y ) of the O-PLS-DA model for classifying into  red and 
control mice at day 3 postinfection was 57%, whereas the 
predictivity value derived from  green and control mice was 
only 25%. The  red -control model showed similar sensitivity as 
the  green -control model (75% versus 78%) but much higher 
specificity (70% versus 8%). As the infection progressed to 
day 4, the urinary metabolic profiles of all infection treat-
ments converged. The metabolites 3-methyl-2-oxovalerate, 
D-3-hydroxybutyrate, 3-carboxy-2-methyl-3-oxopropanamine, 
2-oxoisovalerate, lactate, and pyruvate were found to change 
the relative concentration significantly upon co-infection 
( Table 2 ). However, these metabolites did not show significant 
changes in O-PLS-DA models derived either from each single 
infection versus control or from each single infection versus 
co-infection. The reason is probably that these metabolites 
showed the same trend of changes in the single strain-infected 
mice as in the co-infected mice, but just failed to reach the 
significance level of  P < 0.05 in the single infection models. 
This observation points to a qualitatively identical but quan-
titatively different concentrations of metabolites in multiple 
strain infections. The metabolic response was strikingly dif-
ferent from that of  P. berghei -infected mice, which for exam-
ple exhibited increased pipecolic acid as a unique biomarker 
( Table 2 ). 29 
 An O-PLS-DA model of control and  red -infected mice 
at day 4 is represented in  Figure 3 . Increased urinary 
concentrations of 2-oxoisocaproate, D-3-hydroxybutyrate, 
3-carboxyl-2-methyl-3-oxopropanamine, pyruvate, lactate, 
4-hydroxyphenylacetate, phenylpyruvate, and 4-hydroxyphe-
nylpyruvate, and decreased levels of hippurate, guanidoace-
tate, and 1-methylnicotinamide were found in the  red -infected 
mice compared with uninfected control mice. 
 Correlation between urinary metabolites, parasitemia, 
and blood values.  The relative concentrations of pyruvate 
 Table 2 
 Goodness of fit (R 2 X ), predictivity (Q 2 Y ), and coefficient values of orthogonal signal corrected-projection to latent structure-discriminant analysis 
(O-PLS-DA) models derived from the comparison of infected and control mice on days 3 and 4 postinfection in this study compared with two previ-
ous studies using a different  Trypansoma brucei brucei strain, 21 and a  Plasmodium berghei infection 27 to ascertain specificity of metabolite signature * 
 *  Metabolites significantly contributing to the discrimination between non-infected and  T. b. brucei- infected mice in O-PLS-DA models derived from urinary spectra in this study are highlighted 
using bold-type font. Positive values indicate higher concentrations of the metabolite in the infected mice and vice versa. 
 †  G 7 = infection with 10 
7 parasites of strain STIB777AE-G1; R 7 = infection with 10 
7 parasites of strain STIB246BA-R1; R 7 G 5 = infection with 10 
7 parasites of strain STIB246BA-R1 and 10 5 
parasites of strain STIB777AE-G1; R 7 G 7 = infection with 10 
7 parasites of strain STIB246BA-R1 and 10 7 parasites of strain STIB777AE-G1. 
Parasite  T. b. brucei strains STIB777AE-G1 and STIB246BA-R1
 T. b. brucei strain 
GVR 35  P. berghei 
Treatment † G 7 R 7 R 7 G 5 R 7 G 7 – –
Day postinfection 3 4 3 4 3 4 3 4 21 4
R 2 X – 0.78 0.60 0.80 0.60 0.83 0.44 0.75 0.90 0.35
Q 2 Y 0.30 0.87 0.68 0.95 0.62 0.95 0.70 0.95 0.86 0.57
 Phenylpyruvate 0.89 0.77 0.82 0.81 0.78 0.87 0.92
 Guanidoacetate −0.92 −0.84 −0.96 −0.91 −0.97 −0.88 −0.94
 4-hydroxyphenylpyruvate 0.83 0.81 0.81 0.78 0.84 0.92
Hippurate −0.89 −0.86 −0.86 −0.83 −0.94 −0.71
4-hydroxyphenylacetate 0.89 0.93 0.81 0.82 0.96 0.73
 1-methylnicotinamide −0.92 −0.86 −0.83 −0.90
 2-oxoglutarate −0.84
 2-oxoisocaproate −0.91 −0.88 −0.80 −0.91
3-methyl-2-oxovalerate 0.77 0.80 0.97 0.84
D-3-hydroxybutyrate 0.94 0.74
3-carboxy-2-methyl-3-
oxopropanamine 0.81 0.96 0.75
2-oxoisovalerate 0.84 0.69
Lactate 0.86 0.66
 Pyruvate 0.93
Trimethylamine 0.51
Tryptophan 0.78
Dimethylamine 0.58
Trimethylamine- N -oxide −0.58
Phenylacetylglycine 0.66
Taurine −0.58
Pipecolic acid 0.78
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and phenylpyruvate were strongly positively correlated with 
parasitemia, whereas hippurate showed a weak but statistically 
significant negative correlation ( Figure 4 ), that is, urinary 
hippurate concentration is lower in the infected animals. Three 
mice from three different treatments and three different cages 
were excluded from the regression analysis because they were 
clear outliers that exhibited strikingly different behavior in 
the measured metabolites (but not in survival and weight on 
day 4) from all other data points. 
 DISCUSSION 
 Mice infected with  T. b. brucei strains STIB246BA-R1 
(“ red ”), STIB777AE-G1 (“ green ”), or co-infected with both 
strains revealed similar urinary metabolic signatures, reflecting 
perturbation in host energy metabolism (e.g., lactate, pyruvate, 
and D-3-hydroxybutyrate) and gut microbial metabolism (e.g., 
hippurate and 4-hydroxyphenylacetate). Animals infected only 
with  green showed a slower metabolic response than those 
infected with either  red alone or both strains concurrently. 
These findings suggest that  red is more virulent. Those mice 
infected with the heavier mixed strain load showed a relatively 
greater number of metabolic perturbations than mice from the 
other groups. The same trend was confirmed in the time trajec-
tory comparison between the infected groups, showing that the 
high mixed titer was the only one that induced clear separation 
between all time points assessed (e.g., preinfection and day 1 
postinfection), indicating a stronger pathology-driven tempo-
ral variation. Although the metabolic responses to each of the 
infections were similar, there were many inconsistencies with 
the previously reported metabolic signature of infection with 
GVR35, another  T. b. brucei strain maintained in our laborato-
ries for many years. 23 Similar responses were observed in gut 
microbial metabolites and organic acids, but increased excretion 
of pyruvate, phenylpyruvate, and 4-hydroxyphenylpyruvate 
was one of the key discriminatory features in the current 
series of infections, although it was not observed by Wang 
and colleagues. 23 However,  T. b. brucei strain GVR 35 caused 
a chronic infection with low parasitemia, whereas the infec-
tions in this study were acute with very high levels of para-
sitemia reached within a few days. Hence, the differences in 
the experimental protocols could account for the variation in 
metabolic response between the two studies. In addition, the 
infections in the current study were highly intensive and five 
animals in each group were sufficient to produce strong statis-
tical models. Therefore, fewer animals were used than in our 
previous parasite-host models, which are also justified on ethi-
cal grounds (i.e., 3R rule). 
 The two trypanosome strains used in the current experi-
ment reached basically identical total parasitemia levels in sin-
gle and multiple infections, i.e., both strains were suppressed 
in the mixed infections. We have previously shown that both 
strains are equally suppressed but that suppression is not 
just the cause of the total parasite density, because in a dou-
ble infection with a more slowly growing variant of the  green 
strain used here, suppression of the co-infecting  red strain 
was just as severe, despite much lower total parasitemia. 6 The 
results of this study do not further elucidate the mechanism, 
by which this apparently strain-specific suppression occurs, 
because both strains exhibited virtually indistinguishable 
metabolic profiles and similar profiles were found between 
single and multiple strain infections. 
 Figure 3.  Orthogonal signal corrected-projection to latent struc-
ture-discriminant analysis (O-PLS-DA) coefficient plot derived from 
 1 H nuclear magnetic resonance (NMR) spectra of urine obtained from 
four  red strain-infected mice and five control mice at day 4 postin-
fection. Peaks pointing up show higher concentrations of metabolites 
in the infected group, peaks pointing down lower concentrations. The 
significance of contribution of each peak increases from blue to red. 
Q 2 Y = 0.85. Key to metabolite identification as in  Figure 1 . This figure 
appears in color at  www.ajtmh.org . 
 Figure 4.  Correlation between total parasitemia (sum of  T. b. brucei strains STIB246BA-R1 and STIB777AE-G1) per mouse and relative 
concentrations (in arbitrary units) of three metabolites found to be significantly altered on days 3 and 4 postinfection coded by day postinfection 
(green, day 3; blue, day 4) and treatment (“o,” control; “D,” G 7 ; “+,” R 7 ; “x,” R 7 G 5 ; “à,” R 7 G 7 ; see  Table 2 for treatment details). The three data 
points in parentheses are outliers and were not included in the regression analysis. The dashed line is the linear regression line. This figure appears 
in color at  www.ajtmh.org . 
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 A prominent finding was that the elevated levels of keto-
acids (phenylpyruvate and 4-hydroxyphenylpyruvate), 
indicating alterations in the phenylalanine and tyrosine metab-
olism, which were also observed in  T. b. gambiense 31 and in 
 T. evansi , 32 were correlated with parasitemia. In the study by 
El Sawalhy and colleagues, 32 the levels of phenylpyruvate and 
4-hydroxyphenylpyruvate returned to normal after thera-
peutic intervention. Pyruvate is known to be the primary 
metabolite excreted by  T. brucei . 33, 34 The increased level of 
pyruvate in the host blood may thus simply be the conse-
quence of higher parasite density, an interpretation sup-
ported by the close correlation between parasitemia and 
pyruvate levels reported here. However, phenylpyruvate and 
4-hydroxyphenylpyruvate are also metabolized from phe-
nylalanine and tyrosine, respectively, by L-amino oxidase. 
L-amino oxidase from the venom glands of  Bothrops moojeni 
and  Bothrops jararacussu have been reported to exhibit 
antiviral (against Dengue virus) and antiprotozoal (against 
 Trypanosoma and  Leishmania species) activities. 35, 36 The ele-
vated levels of phenylpyruvate and 4-hydroxyphenylpyru-
vate could also be caused by an increased L-amino oxidase 
activity in  T. b. brucei -infected mice. Future studies should 
assess the activity of this enzyme  in vivo . The 4-hydroxy-
phenylacetate is derived from 4-hydroxyphenylpyruvate by 
4-hydroxyphenylpyruvate oxidase and the increased concen-
tration of this metabolite was consistent with the higher level 
of 4-hydroxyphenylpyruvate. Although it is not clear to what 
extent these further metabolites are produced by parasite or 
host metabolism, the increase of these metabolites is the most 
marked feature in  T. b. brucei -infected hosts. 
 The 1-methylnicotinamide, which was significantly decreased 
in infected mice, is involved in the nicotinate metabolism 
and is mainly produced from nicotinamide by nicotinamide 
 N -methyltransferase (NNMT) in the liver. This metabo-
lite has previously been reported to be associated with anti-
thrombotic activity 37 and may explain why infected mice con-
sistently exhibited drastic thrombocytopenia as the first sign 
of disease. The 2-oxoisocaproate, which is derived from leu-
cine, was found to be present in lower concentrations in all 
infected animals at day 4. This observation is in agreement 
with a decreased plasma level of leucine in the  T. b. brucei -
infected mice reported previously. 23 
 In conclusion, this study has shown that two different strains 
of  T. b. brucei resulted in similar metabolic profiles in the mouse, 
but there were a number of minor, yet significant, quantita-
tive differences. We speculate that the metabolic differences 
between single and multiple strain infections observed at dif-
ferent time points are likely attributable to the infection inten-
sity and disease progression. As far as we know, this is the first 
study comparing the metabolic signature of multiple strains 
of a single parasite species in a rodent model. We only found 
subtle strain differences, which might be partially explained by 
the small number of mice in each group ( N = 5). However, we 
would like to caution against the conclusion that strain identity 
can therefore be neglected. On the contrary , strain specificity 
and multiplicity are important factors for disease progression 
and severity, and have significant leverage on treatment of two 
reasons. First, there are several mechanisms by which multiple 
strain infections may be relevant that could not be investigated 
here and that are not captured by metabolic responses. 6 Second, 
our results are based on only two strains of a genetically highly 
variable parasite. The relevance of these findings have yet to be 
fully elucidated, but might well play a role for a deeper under-
standing of host-parasite interactions, personalized healthcare, 
and the monitoring of disease control interventions. 
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